Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
05/2008
05/14/2008CN101180294A Pyran/dioxan derivatives and use thereof in liquid crystal media
05/14/2008CN101180293A Naphthalamide derivatives having antiproliferative activity
05/14/2008CN101180285A Formyltetrahydropyrans, method for the production thereof and use thereof in the production of liquid crystal compounds
05/14/2008CN101177424A High-purity silybin meglumine, preparation method as well as application in preparing medicine treating hepatitis and liver hurt thereof
05/14/2008CN100387706C Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis
05/13/2008US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields
05/13/2008US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action
05/13/2008US7371772 Bicyclic compound, production and use thereof
05/13/2008US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties
05/13/2008US7371745 Bis-transition-metal-chelate probes
05/08/2008WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
05/08/2008US20080108837 Separating a terpene trilactone from Ginkgo biloba plant material; column chromatography; large-scale isolation of ginkgolides as phytopharmaceuticals
05/08/2008US20080108610 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae)
05/08/2008US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics
05/08/2008US20080107821 Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound
05/08/2008US20080105865 Pyrene Based Compound and Light Emitting Transistor Element Using the Same
05/08/2008CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors
05/07/2008EP1917323A1 Novel materials for organic electroluminescent devices
05/07/2008EP1917260A2 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method
05/07/2008CN101175748A N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
05/07/2008CN101175740A Dihydrobenzofuran derivatives and uses thereof
05/07/2008CN101172971A Preparation for chemical composition of Shenmai injection and application in treating cardiovascular and cerebrovascular diseases thereof
05/06/2008US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl.
05/06/2008US7368582 Potassium channel blocker; sulfonylation of the corresponding 4-aminochromene; cardiac arrhythmias; marked atrial-selective action profile; proliferative diseases, chronic inflammatory diseases, autoimmune diseases
05/06/2008US7368579 E.g., 2-bromo- or 2-chloro-1-(2-methyl-2-oxiranylmethyl)-4-nitroimidazole; intermediates for antitubercular agents
05/06/2008US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
05/06/2008US7368434 Alcoholism therapy
05/06/2008US7368101 Process for the preparation of iopamidol and the new intermediates therein
05/06/2008CA2244979C Proton conductor in liquid form
05/02/2008WO2008049923A1 CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
05/02/2008WO2008049875A1 Novel substituted piperidyl-propane-thiols
05/02/2008CA2667550A1 Crystalline form of 4-(.beta.-d-glucopyranos-1-yl)-1-methyl-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
05/02/2008CA2667548A1 Substituted piperidyl-propane-thiols
05/01/2008US20080103320 Total Synthesis of Myriaporones
05/01/2008US20080103194 Anti-first-pass effect compounds
04/2008
04/30/2008EP1916249A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
04/29/2008US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders
04/23/2008EP1914229A1 Novel cercosporamide derivative
04/23/2008EP1912972A1 Substituted imidazole compounds as ksp inhibitors
04/23/2008EP1635828B1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
04/23/2008EP1007033B1 Lymphocyte function antigen-1 antagonists
04/23/2008CN101166737A Phosphodiesterase 4 inhibitors
04/23/2008CN101166733A Pyrazole derivatives as phosphodiesterase 4 inhibitors
04/23/2008CN101166723A New compound for the treatinginflammatory disease
04/17/2008WO2008045945A1 Benzindole derivatives and method of treating hiv/aids
04/17/2008WO2008044217A2 2-aminocarbonyl-pyridine derivatives
04/17/2008WO2008043733A1 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
04/17/2008WO2008011117A3 Antiviral protease inhibitors
04/17/2008WO2008008887A3 Gpr119 agonists for treating metabolic disorders
04/17/2008US20080090901 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-chagas chemoprophylactic and therapeutical activities
04/17/2008CA2664579A1 2-aminocarbonyl-pyridine derivatives
04/16/2008EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists
04/16/2008EP1909791A1 G-protein coupled receptor agonists
04/16/2008EP1909572A2 Potassium channel inhibitors
04/16/2008EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents
04/16/2008CN100381437C Compounds, compositions and methods
04/16/2008CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof
04/15/2008US7358377 Schweinfurthin analogues
04/15/2008CA2343310C Polymerizable polyalkoxylated naphthopyrans
04/10/2008WO2008042688A2 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
04/10/2008WO2008040528A2 Process for preparing nebivolol
04/10/2008WO2008040097A1 Furanone compounds and lactam analogues thereof
04/10/2008WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
04/10/2008US20080086010 reacting 4-chloro-3-methyl-5-(3-oxo-thieno(2,3-d) isothiazole-1,1-dioxide with 5-methyl-7-metal, metal halide or metal complex-methyl-,13-benzodioxole
04/10/2008US20080085929 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
04/10/2008CA2664688A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
04/10/2008CA2663339A1 Process for preparing nebivolol
04/09/2008EP1907382A1 Nitrocatechol derivatives as comt inhibitors
04/09/2008EP1907380A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis
04/09/2008EP1907362A1 Amide derivatives as kinase inhibitors
04/09/2008EP1907361A1 Amide derivatives as kinase inhibitors
04/09/2008EP1594867B1 Phenylacetamides and their use as glucokinase modulators
04/09/2008CN101160305A Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
04/09/2008CN101157689A Complex salt of Silybin and oxymatrine or matrine and uses thereof
04/08/2008US7355054 Indole derivatives
04/03/2008WO2008039645A1 Compounds which modulate the cb2 receptor
04/03/2008WO2007135565A3 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
04/03/2008CA2664310A1 Compounds which modulate the cb2 receptor
04/02/2008EP1904486A2 Processes for the synthesis of 3-isobutylglutaric acid
04/02/2008EP1904485A2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use
04/02/2008EP1729759A4 Salvinorin derivatives and uses thereof
04/02/2008CN101153038A A process for the preparation of phenyltetrazole compounds
04/01/2008US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide
04/01/2008US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias
04/01/2008CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
03/2008
03/27/2008WO2008036216A1 Piperidine derivatives as renin inhibitors
03/27/2008WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/27/2008WO2008011560A3 Benzothiophene inhibitors of rho kinase
03/27/2008WO2008009405A3 Novel pyridazine derivatives
03/27/2008WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9
03/27/2008WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
03/27/2008WO2007136573A3 Antidiabetic bicyclic compounds
03/27/2008WO2007103370A3 Quinazoline derivatives as phosphodiesterase 10 inhibitors
03/27/2008US20080076817 Neurotrophic N-glyoxyl-prolyl ester compounds e.g. 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; non-immunosuppressive; side effect reduction; neurodegenerative diseases
03/27/2008CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/26/2008CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives
03/26/2008CN101148444A Flavone derivative, preparation method and application
03/26/2008CN101148442A Histone deacetylase inhibitor and its preparation method and use
03/26/2008CN100376569C Inhibitors of farnesyl protein transferase
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 120